| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/HV.27600 |
| P8608 | Fatcat ID | release_5otd3xjwe5es7po6mimwz3giji |
| P932 | PMC publication ID | 4130286 |
| P698 | PubMed publication ID | 24378716 |
| P5875 | ResearchGate publication ID | 259498998 |
| P50 | author | Rino Rappuoli | Q2154243 |
| Philip R Dormitzer | Q101423214 | ||
| P2093 | author name string | Ethan C Settembre | |
| P2860 | cites work | 1918 Influenza: the mother of all pandemics | Q22305649 |
| Antibody recognition of a highly conserved influenza virus epitope | Q24655932 | ||
| Avian flu: influenza virus receptors in the human airway | Q29619374 | ||
| Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. | Q30369076 | ||
| HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. | Q30374103 | ||
| Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. | Q30375250 | ||
| Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 | ||
| Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays | Q30400686 | ||
| Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines | Q30401079 | ||
| MF59 adjuvant: the best insurance against influenza strain diversity | Q30402018 | ||
| Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion | Q30416728 | ||
| Influenza: options to improve pandemic preparation | Q30418373 | ||
| Advances in the development of universal influenza vaccines | Q30421502 | ||
| Synthetic generation of influenza vaccine viruses for rapid response to pandemics | Q30430578 | ||
| Influenza virus vaccine based on the conserved hemagglutinin stalk domain | Q34030587 | ||
| A novel synthetic receptor-based immunoassay for influenza vaccine quantification | Q34592631 | ||
| Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds | Q34776101 | ||
| Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease | Q34976021 | ||
| Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. | Q35882085 | ||
| Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs | Q36017724 | ||
| A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines | Q36629843 | ||
| Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. | Q36804151 | ||
| Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies | Q36911722 | ||
| Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. | Q37444287 | ||
| Combination of adjuvants: the future of vaccine design | Q38124060 | ||
| Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. | Q43919615 | ||
| Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs | Q44077186 | ||
| Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards | Q44282826 | ||
| Evidence for host-cell selection of influenza virus antigenic variants | Q45804806 | ||
| A novel assay for influenza virus quantification using surface plasmon resonance. | Q51562876 | ||
| Oil-in-water emulsion adjuvant with influenza vaccine in young children | Q85087747 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| P304 | page(s) | 600-604 | |
| P577 | publication date | 2013-12-30 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Bringing influenza vaccines into the 21st century. | |
| P478 | volume | 10 |
| Q90018307 | Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing |
| Q52609655 | New Kids on the Block: RNA-Based Influenza Virus Vaccines. |
| Q52599675 | Novel Platforms for the Development of a Universal Influenza Vaccine. |
| Q30359975 | Perspective: Ill prepared for a pandemic. |
| Q40779990 | Positive Contribution of Adjuvanted Influenza Vaccines to the Resolution of Bacterial Superinfections |
| Q36550981 | Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases |
Search more.